SG Americas Securities
ATYR

SG Americas Securities’s aTyr Pharma ATYR Stock Holding History

SG Americas Securities’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,032
Closed -$19K – 3793
2025
Q4 		$19K Buy
24,032
+2,569
+12% +$2.11K ﹤0.01% 3472
2025
Q3 		$15K Buy
+21,463
New +$97.3K ﹤0.01% 3305
2024
Q2 		– Sell
-28,256
Closed -$55K – 3381
2024
Q1 		$55K Buy
+28,256
New +$49.3K ﹤0.01% 2742

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's ATYR Position: Q1 2026 in Review

SG Americas Securities sold out of aTyr Pharma (ATYR) in Q1 2026, closing a stake of 24,032 shares — an estimated $19K sold.

SG Americas Securities first reported a position in ATYR in Q1 2024 and held it in 3 quarters. The position peaked at $55K in Q1 2024. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • SG Americas Securities reported no remaining aTyr Pharma position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 24,032 aTyr Pharma shares in Q1 2026, an estimated $19K.
  • SG Americas Securities first reported a position in aTyr Pharma in Q1 2024 and held it in 3 quarters.
  • SG Americas Securities's aTyr Pharma position peaked at $55K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.